https://www.selleckchem.com/pr....oducts/lenalidomide-
Patients with CKD are at elevated risk of metabolic acidosis due to impaired net acid excretion (NAE). Identifying early markers of acidosis may guide prevention in chronic kidney disease (CKD). This study compared NAE in participants with and without CKD, as well as the NAE, blood pressure (BP), and metabolomic response to bicarbonate supplementation. Randomized order, cross-over study with controlled feeding. Participants consisted of 8 patients with CKD (estimated glomerular filtration rate 30-59mL/min/1.73m or 60-70mL/min
Mi piace
Commento
Condividi
